• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用无毒突变体中毒性休克综合征毒素-1进行疫苗接种可诱导依赖白细胞介素-17的抗金黄色葡萄球菌感染保护作用。

Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against Staphylococcus aureus infection.

作者信息

Narita Kouji, Hu Dong-Liang, Asano Krisana, Nakane Akio

机构信息

Department of Microbiology and Immunology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036-8562, Japan Institute for Animal Experimentation, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036-8562, Japan.

Department of Microbiology and Immunology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036-8562, Japan Laboratory of Zoonoses, Kitasato University School of Veterinary Medicine, Towada, Aomori 034-8628, Japan.

出版信息

Pathog Dis. 2015 Jun;73(4). doi: 10.1093/femspd/ftv023. Epub 2015 Apr 9.

DOI:10.1093/femspd/ftv023
PMID:25857736
Abstract

Toxic shock syndrome toxin-1 (TSST-1) is one of superantigens produced by Staphylococcus aureus. We have previously demonstrated that vaccination with non-toxic mutant TSST-1 (mTSST-1) develops host protection to lethal S. aureus infection in mice. However, the detailed mechanism underlying this protection is necessary to elucidate because the passive transfer of antibodies against TSST-1 fails to provide complete protection against S. aureus infection. In this study, the results showed that interleukin-17A (IL-17A)-producing cells were increased in the spleen cells of mTSST-1-vaccinated mice. The main source of IL-17A in mTSST-1-vaccinated mice was T-helper 17 (Th17) cells. The protective effect of vaccination was induced when the vaccinated wild type but not IL-17A-deficient mice were challenged with S. aureus. Gene expression of chemokines, CCL2 and CXCL1, and infiltration of neutrophils and macrophages were increased in spleens and livers of vaccinated mice after infection. The IL-17A-dependent immune response was TSST-1 specific because TSST-1-deficient S. aureus failed to induce the response. The present study suggests that mTSST-1 vaccination is able to provide the IL-17A-dependent host defense against S. aureus infection which promotes chemokine-mediated infiltration of phagocytes into the infectious foci.

摘要

中毒性休克综合征毒素-1(TSST-1)是金黄色葡萄球菌产生的超抗原之一。我们之前已经证明,用无毒突变体TSST-1(mTSST-1)进行疫苗接种可使小鼠对致死性金黄色葡萄球菌感染产生宿主保护作用。然而,由于针对TSST-1的抗体被动转移未能提供针对金黄色葡萄球菌感染的完全保护,因此有必要阐明这种保护作用的详细机制。在本研究中,结果显示,接种mTSST-1的小鼠脾细胞中产生白细胞介素-17A(IL-17A)的细胞增加。接种mTSST-1的小鼠中IL-17A的主要来源是辅助性T细胞17(Th17)细胞。当接种疫苗的野生型小鼠而非IL-17A缺陷型小鼠受到金黄色葡萄球菌攻击时,诱导出了疫苗接种的保护作用。感染后,接种疫苗的小鼠脾脏和肝脏中趋化因子CCL2和CXCL1的基因表达以及中性粒细胞和巨噬细胞的浸润增加。IL-17A依赖性免疫反应具有TSST-1特异性,因为缺乏TSST-1的金黄色葡萄球菌无法诱导该反应。本研究表明,mTSST-1疫苗接种能够提供针对金黄色葡萄球菌感染的IL-17A依赖性宿主防御,促进趋化因子介导的吞噬细胞浸润到感染灶中。

相似文献

1
Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against Staphylococcus aureus infection.用无毒突变体中毒性休克综合征毒素-1进行疫苗接种可诱导依赖白细胞介素-17的抗金黄色葡萄球菌感染保护作用。
Pathog Dis. 2015 Jun;73(4). doi: 10.1093/femspd/ftv023. Epub 2015 Apr 9.
2
Interleukin-10 (IL-10) Produced by Mutant Toxic Shock Syndrome Toxin 1 Vaccine-Induced Memory T Cells Downregulates IL-17 Production and Abrogates the Protective Effect against Staphylococcus aureus Infection.白细胞介素-10(IL-10)由突变型中毒性休克综合征毒素 1 疫苗诱导的记忆 T 细胞产生,可下调白细胞介素-17 的产生,并消除其对金黄色葡萄球菌感染的保护作用。
Infect Immun. 2019 Sep 19;87(10). doi: 10.1128/IAI.00494-19. Print 2019 Oct.
3
Vaccination with plasmid DNA encoding a mutant toxic shock syndrome toxin-1 ameliorates toxin-induced lethal shock in mice.接种编码突变型毒性休克综合征毒素-1 的质粒 DNA 可改善毒素诱导的小鼠致死性休克。
Tohoku J Exp Med. 2013 Sep;231(1):1-8. doi: 10.1620/tjem.231.1.
4
Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection.用无毒突变体毒性休克综合征毒素1进行疫苗接种可预防金黄色葡萄球菌感染。
J Infect Dis. 2003 Sep 1;188(5):743-52. doi: 10.1086/377308. Epub 2003 Aug 14.
5
Immunization with glutathione S-transferase and mutant toxic shock syndrome toxin 1 fusion protein protects against Staphylococcus aureus infection.用谷胱甘肽S-转移酶与突变型中毒性休克综合征毒素1融合蛋白进行免疫可预防金黄色葡萄球菌感染。
FEMS Immunol Med Microbiol. 2005 Jul 1;45(1):45-51. doi: 10.1016/j.femsim.2005.01.010. Epub 2005 Feb 10.
6
IL-17A plays an important role in protection induced by vaccination with fibronectin-binding domain of fibronectin-binding protein A against Staphylococcus aureus infection.白细胞介素-17A在用纤连蛋白结合蛋白A的纤连蛋白结合结构域疫苗接种诱导的针对金黄色葡萄球菌感染的保护中发挥重要作用。
Med Microbiol Immunol. 2017 Jun;206(3):225-234. doi: 10.1007/s00430-017-0499-9. Epub 2017 Apr 4.
7
Intranasal immunization of mutant toxic shock syndrome toxin 1 elicits systemic and mucosal immune response against Staphylococcus aureus infection.突变型中毒性休克综合征毒素1的鼻内免疫引发针对金黄色葡萄球菌感染的全身和黏膜免疫反应。
FEMS Immunol Med Microbiol. 2008 Apr;52(3):389-96. doi: 10.1111/j.1574-695X.2008.00384.x. Epub 2008 Feb 27.
8
Intranasal vaccination with a double mutant of staphylococcal enterotoxin C provides protection against Staphylococcus aureus infection.用葡萄球菌肠毒素C的双突变体进行鼻内接种可预防金黄色葡萄球菌感染。
Microbes Infect. 2006 Nov-Dec;8(14-15):2841-8. doi: 10.1016/j.micinf.2006.09.001. Epub 2006 Oct 11.
9
Contribution of toxic shock syndrome toxin-1 to systemic inflammation investigated by a mouse model of cervicovaginal infection with Staphylococcus aureus.通过金黄色葡萄球菌引起的宫颈阴道感染小鼠模型研究中毒性休克综合征毒素-1对全身炎症的贡献。
Med Microbiol Immunol. 2018 Nov;207(5-6):297-306. doi: 10.1007/s00430-018-0551-4. Epub 2018 Jul 6.
10
Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens.交叉反应性抗体可预防金黄色葡萄球菌超抗原的致死效应。
J Infect Dis. 1999 Oct;180(4):1365-9. doi: 10.1086/314977.

引用本文的文献

1
Toxic Shock Syndrome Toxin-1 (TSST-1) in : Prevalence, Molecular Mechanisms, and Public Health Implications.中毒性休克综合征毒素-1(TSST-1):流行情况、分子机制及对公共卫生的影响
Toxins (Basel). 2025 Jun 24;17(7):323. doi: 10.3390/toxins17070323.
2
Toxic Shock Syndrome Toxin 1 Induces Immune Response via the Activation of NLRP3 Inflammasome.毒性休克综合征毒素 1 通过激活 NLRP3 炎性体诱导免疫应答。
Toxins (Basel). 2021 Jan 18;13(1):68. doi: 10.3390/toxins13010068.
3
Allergy-A New Role for T Cell Superantigens of ?超抗原在过敏反应中的新作用?
Toxins (Basel). 2020 Mar 12;12(3):176. doi: 10.3390/toxins12030176.
4
Interleukin-10 (IL-10) Produced by Mutant Toxic Shock Syndrome Toxin 1 Vaccine-Induced Memory T Cells Downregulates IL-17 Production and Abrogates the Protective Effect against Staphylococcus aureus Infection.白细胞介素-10(IL-10)由突变型中毒性休克综合征毒素 1 疫苗诱导的记忆 T 细胞产生,可下调白细胞介素-17 的产生,并消除其对金黄色葡萄球菌感染的保护作用。
Infect Immun. 2019 Sep 19;87(10). doi: 10.1128/IAI.00494-19. Print 2019 Oct.
5
IL-17 in Renal Immunity and Autoimmunity.白细胞介素-17 在肾脏免疫和自身免疫中的作用。
J Immunol. 2018 Dec 1;201(11):3153-3159. doi: 10.4049/jimmunol.1801042.
6
Whole-genome epidemiology, characterisation, and phylogenetic reconstruction of Staphylococcus aureus strains in a paediatric hospital.对儿科医院金黄色葡萄球菌株进行全基因组流行病学、特征分析和系统发育重建。
Genome Med. 2018 Nov 13;10(1):82. doi: 10.1186/s13073-018-0593-7.
7
IL-17A plays an important role in protection induced by vaccination with fibronectin-binding domain of fibronectin-binding protein A against Staphylococcus aureus infection.白细胞介素-17A在用纤连蛋白结合蛋白A的纤连蛋白结合结构域疫苗接种诱导的针对金黄色葡萄球菌感染的保护中发挥重要作用。
Med Microbiol Immunol. 2017 Jun;206(3):225-234. doi: 10.1007/s00430-017-0499-9. Epub 2017 Apr 4.
8
Superantigens of a superbug: Major culprits of Staphylococcus aureus disease?超级细菌的超抗原:金黄色葡萄球菌疾病的主要元凶?
Virulence. 2017 Aug 18;8(6):607-610. doi: 10.1080/21505594.2016.1255399. Epub 2016 Nov 2.
9
The Role of Neutrophils in the Induction of Specific Th1 and Th17 during Vaccination against Tuberculosis.中性粒细胞在抗结核疫苗接种过程中诱导特异性Th1和Th17细胞中的作用
Front Microbiol. 2016 Jun 10;7:898. doi: 10.3389/fmicb.2016.00898. eCollection 2016.
10
Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant.通过纳米乳剂佐剂的黏膜给药对TH2偏向性免疫进行免疫调节。
Vaccine. 2016 Jul 25;34(34):4017-24. doi: 10.1016/j.vaccine.2016.06.043. Epub 2016 Jun 23.